Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Abnormalities of Motor Imagery and Relationship With Depressive Symptoms in Mildly Disabling Relapsing-Remitting Multiple Sclerosis.
Neuromyelitis optica.
Stabilization of rapidly worsening multiple sclerosis for 36 months in patients treated with interferon beta plus cyclophosphamide followed by interferon beta.
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).
Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis.
CHMP recommends granting a marketing authorization for Santhera's Raxone® for the treatment of Leber's Hereditary Optic Neuropathy (LHON)
Sleep Disorders and Multiple Sclerosis: A Clinical and Polysomnography Study.
Glossopharyngeal neuralgia secondary to vascular compression in a patient with multiple sclerosis: a case report.
Evaluation of sexual function in women at two stages of multiple sclerosis.
Multiplexing analysis of the polyspecific intrathecal immune response in multiple sclerosis.
Oligoclonal band and multiple sclerosis risk in monosymptomatic optic neuritis patients: a retrospective study of 84 patients.
New data at ENS show Novartis drug Gilenya benefited patients by improving all four key measures of multiple sclerosis
Diagnosis of exclusion: a case report of probable glatiramer acetate-induced eosinophilic myocarditis.
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - A twelve month follow-up.
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
Food and Drug Administration briefing document for ofatumumab
Preclinical retinal neurodegeneration in a model of multiple sclerosis.
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis.
Teva and Takeda announce agreement for glatiramer acetate for multiple sclerosis treatment in Japan
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: a long-term follow-up study.
Receptos begins enrollment of Phase 3 trial of RPC1063 in relapsing multiple sclerosis
Tysabri

Pages